The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market size has grown rapidly in recent years. It will grow from $1.24 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 18.6%. The growth in the historic period can be attributed to rise in neurological disorder prevalence, early adoption of robotic rehabilitation devices, advancements in sensor technologies, demand for intensive rehabilitation therapies, growth of rehabilitation centers.
The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market size is expected to see rapid growth in the next few years. It will grow to $2.87 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to AI-enabled adaptive rehabilitation, expansion of home-based neurorehabilitation, increasing geriatric population, reimbursement support for robotic therapy, integration of cloud-based analytics. Major trends in the forecast period include personalized ai-driven rehabilitation programs, adaptive motion assistance systems, data-driven therapy outcome tracking, home-based robotic rehabilitation, integration with clinical rehabilitation protocols.
The rising incidence of neurological disorders is expected to drive the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market in the coming years. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to impairments in movement, cognition, sensation, or other bodily functions. The global increase in neurological disorders is largely attributed to an aging population, as older adults are more susceptible to conditions such as stroke, dementia, and Parkinson’s disease, which tend to become more prevalent with age. Artificial intelligence (AI) enhanced neurorehabilitation exoskeletons assist individuals with neurological disorders by providing personalized, adaptive therapy that improves motor function, accelerates recovery, and compensates for movement impairments through real-time monitoring and intelligent adjustments to each patient’s specific needs. For example, in March 2023, according to the Alzheimer’s Association, a US-based nonprofit health organization, approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia, and this number is projected to reach 13.8 million by 2060. Hence, the increasing incidence of neurological disorders is fueling the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market.
Major players in the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market are emphasizing the integration of innovative technologies such as robotic control systems to enhance mobility, stability, and rehabilitation outcomes. Robotic control systems are technologies that coordinate and manage the movements of a robot or exoskeleton, helping users walk, stand, and perform daily activities safely and efficiently by enabling precise, stable, and adaptive motion. For instance, in May 2025, Wandercraft SAS, a France-based robotics company, initiated clinical trials in the United States for its AI-powered personal exoskeleton. The device integrates advanced physical AI and robotic control systems to assist individuals with spinal cord injuries, stroke, and other mobility impairments in standing, walking, and navigating various surfaces safely. Continuously adapting to user movements in real time, it improves mobility, stability, and rehabilitation outcomes. Equipped with a joystick-based control system and intelligent algorithms that anticipate changes in weight, surface, and speed, the exoskeleton promotes greater independence while minimizing secondary health risks associated with long-term wheelchair use.
In July 2025, Moody Neurorehabilitation Institute Inc., a US-based healthcare organization, acquired Wandercraft SAS’s Atalante X exoskeleton for an undisclosed amount. Through this acquisition, Moody Neurorehabilitation Institute Inc. aims to strengthen its rehabilitation capabilities by offering high-intensity, hands-free gait therapy, improving outcomes for patients with complex mobility challenges, including those recovering from traumatic brain injuries. Wandercraft SAS is a France-based medical robotics company that specializes in providing AI enhanced neurorehabilitation exoskeletons.
Major companies operating in the artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market are Ottobock SE & Co. KGaA, Shanghai Fourier Intelligence Co. Ltd., Kinova Inc., Cyberdyne Inc., Hocoma AG, Myomo Inc., Neofect Co. Ltd., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., AlterG Inc., RENU ROBOTICS CORPORATION, ExoAtlet Global S.A., REEV Robotics, Bionik Laboratories Corp., Rex Bionics PLC, Wearable Robotics Srl, Gogoa Mobility Robots S.L., Technaid S.L., Bionic Yantra Pvt. Ltd., MediTouch Inc.
North America was the largest region in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market in 2025. The regions covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the AI-enhanced neurorehabilitation exoskeleton market by increasing costs of imported actuators, sensors, and embedded electronics, affecting adoption across hospitals and rehabilitation centers, particularly in North America and Europe. Mobile and powered exoskeleton segments face higher pricing pressures due to dependency on precision components sourced from Asia-Pacific manufacturing hubs. However, tariffs are encouraging local manufacturing, regional supply chain development, and innovation in cost-efficient exoskeleton designs, supporting long-term market resilience.
The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market statistics, including artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market share, detailed artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry. This artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An AI-enhanced neurorehabilitation exoskeleton is a wearable robotic system designed to support and optimize motor recovery through intelligent, adaptive control. By leveraging advanced AI algorithms, the system continuously analyzes the user’s movement patterns to provide personalized and precise assistance during therapy sessions. Through real-time feedback and dynamic adjustments, it facilitates efficient rehabilitation by improving coordination, muscle strength, and overall functional mobility over time.
The key components of artificial intelligence (AI)-enhanced neurorehabilitation exoskeletons include hardware, software, and services. Hardware encompasses the physical elements of the exoskeleton that enable safe, effective, and user-responsive assisted movement. These devices can be classified based on mobility type as either mobile or stationary and integrate various technologies, such as powered, passive, or hybrid systems. They are applied across multiple therapeutic domains, including stroke rehabilitation, spinal cord injury, traumatic brain injury, and multiple sclerosis. The main end-users of these exoskeletons include hospitals and clinics, rehabilitation centers, and home care settings, where they enhance recovery outcomes and promote patient independence.
The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market consists of revenues earned by entities by providing services such as patient assessment services, therapy planning services, remote monitoring services, maintenance and support services, and rehabilitation consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market also includes sales of brain-computer interface (BCI)-controlled exoskeletons, occupational exoskeletons for healthcare workers, AI-integrated exoskeletons with advanced sensors, and modular and customizable exoskeleton systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market size is expected to see rapid growth in the next few years. It will grow to $2.87 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to AI-enabled adaptive rehabilitation, expansion of home-based neurorehabilitation, increasing geriatric population, reimbursement support for robotic therapy, integration of cloud-based analytics. Major trends in the forecast period include personalized ai-driven rehabilitation programs, adaptive motion assistance systems, data-driven therapy outcome tracking, home-based robotic rehabilitation, integration with clinical rehabilitation protocols.
The rising incidence of neurological disorders is expected to drive the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market in the coming years. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to impairments in movement, cognition, sensation, or other bodily functions. The global increase in neurological disorders is largely attributed to an aging population, as older adults are more susceptible to conditions such as stroke, dementia, and Parkinson’s disease, which tend to become more prevalent with age. Artificial intelligence (AI) enhanced neurorehabilitation exoskeletons assist individuals with neurological disorders by providing personalized, adaptive therapy that improves motor function, accelerates recovery, and compensates for movement impairments through real-time monitoring and intelligent adjustments to each patient’s specific needs. For example, in March 2023, according to the Alzheimer’s Association, a US-based nonprofit health organization, approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia, and this number is projected to reach 13.8 million by 2060. Hence, the increasing incidence of neurological disorders is fueling the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market.
Major players in the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market are emphasizing the integration of innovative technologies such as robotic control systems to enhance mobility, stability, and rehabilitation outcomes. Robotic control systems are technologies that coordinate and manage the movements of a robot or exoskeleton, helping users walk, stand, and perform daily activities safely and efficiently by enabling precise, stable, and adaptive motion. For instance, in May 2025, Wandercraft SAS, a France-based robotics company, initiated clinical trials in the United States for its AI-powered personal exoskeleton. The device integrates advanced physical AI and robotic control systems to assist individuals with spinal cord injuries, stroke, and other mobility impairments in standing, walking, and navigating various surfaces safely. Continuously adapting to user movements in real time, it improves mobility, stability, and rehabilitation outcomes. Equipped with a joystick-based control system and intelligent algorithms that anticipate changes in weight, surface, and speed, the exoskeleton promotes greater independence while minimizing secondary health risks associated with long-term wheelchair use.
In July 2025, Moody Neurorehabilitation Institute Inc., a US-based healthcare organization, acquired Wandercraft SAS’s Atalante X exoskeleton for an undisclosed amount. Through this acquisition, Moody Neurorehabilitation Institute Inc. aims to strengthen its rehabilitation capabilities by offering high-intensity, hands-free gait therapy, improving outcomes for patients with complex mobility challenges, including those recovering from traumatic brain injuries. Wandercraft SAS is a France-based medical robotics company that specializes in providing AI enhanced neurorehabilitation exoskeletons.
Major companies operating in the artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market are Ottobock SE & Co. KGaA, Shanghai Fourier Intelligence Co. Ltd., Kinova Inc., Cyberdyne Inc., Hocoma AG, Myomo Inc., Neofect Co. Ltd., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., AlterG Inc., RENU ROBOTICS CORPORATION, ExoAtlet Global S.A., REEV Robotics, Bionik Laboratories Corp., Rex Bionics PLC, Wearable Robotics Srl, Gogoa Mobility Robots S.L., Technaid S.L., Bionic Yantra Pvt. Ltd., MediTouch Inc.
North America was the largest region in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market in 2025. The regions covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the AI-enhanced neurorehabilitation exoskeleton market by increasing costs of imported actuators, sensors, and embedded electronics, affecting adoption across hospitals and rehabilitation centers, particularly in North America and Europe. Mobile and powered exoskeleton segments face higher pricing pressures due to dependency on precision components sourced from Asia-Pacific manufacturing hubs. However, tariffs are encouraging local manufacturing, regional supply chain development, and innovation in cost-efficient exoskeleton designs, supporting long-term market resilience.
The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report is one of a series of new reports that provides artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market statistics, including artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry global market size, regional shares, competitors with a artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market share, detailed artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry. This artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An AI-enhanced neurorehabilitation exoskeleton is a wearable robotic system designed to support and optimize motor recovery through intelligent, adaptive control. By leveraging advanced AI algorithms, the system continuously analyzes the user’s movement patterns to provide personalized and precise assistance during therapy sessions. Through real-time feedback and dynamic adjustments, it facilitates efficient rehabilitation by improving coordination, muscle strength, and overall functional mobility over time.
The key components of artificial intelligence (AI)-enhanced neurorehabilitation exoskeletons include hardware, software, and services. Hardware encompasses the physical elements of the exoskeleton that enable safe, effective, and user-responsive assisted movement. These devices can be classified based on mobility type as either mobile or stationary and integrate various technologies, such as powered, passive, or hybrid systems. They are applied across multiple therapeutic domains, including stroke rehabilitation, spinal cord injury, traumatic brain injury, and multiple sclerosis. The main end-users of these exoskeletons include hospitals and clinics, rehabilitation centers, and home care settings, where they enhance recovery outcomes and promote patient independence.
The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market consists of revenues earned by entities by providing services such as patient assessment services, therapy planning services, remote monitoring services, maintenance and support services, and rehabilitation consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market also includes sales of brain-computer interface (BCI)-controlled exoskeletons, occupational exoskeletons for healthcare workers, AI-integrated exoskeletons with advanced sensors, and modular and customizable exoskeleton systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Characteristics
3. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Supply Chain Analysis
4. Global Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Trends and Strategies
5. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Analysis of End Use Industries
7. Global Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Total Addressable Market (TAM) Analysis for the Market
9. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Segmentation
10. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Regional and Country Analysis
11. Asia-Pacific Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
12. China Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
13. India Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
14. Japan Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
15. Australia Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
16. Indonesia Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
17. South Korea Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
18. Taiwan Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
19. South East Asia Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
20. Western Europe Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
21. UK Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
22. Germany Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
23. France Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
24. Italy Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
25. Spain Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
26. Eastern Europe Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
27. Russia Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
28. North America Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
29. USA Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
30. Canada Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
31. South America Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
32. Brazil Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
33. Middle East Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
34. Africa Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market
36. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Landscape and Company Profiles
37. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market Other Major and Innovative Companies
40. Artificial Intelligence (Ai)-Enhanced Neurorehabilitation Exoskeleton Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Hardware; Software; Services2) By Mobility Type: Mobile; Stationary
3) By Application: Stroke Rehabilitation; Spinal Cord Injury; Traumatic Brain Injury; Multiple Sclerosis
4) By End-User: Hospitals And Clinics; Rehabilitation Centers; Home Care Settings
Subsegments:
1) By Hardware: Exoskeleton Frames; Actuators And Motors; Sensors And Wearable Devices; Control Units And Embedded Electronics2) By Software: Motion Planning Software; Rehabilitation Protocol Software; Data Analytics And Monitoring Software; Connectivity And Integration Software
3) By Services: Implementation And Setup Services; Training And Education Services; Maintenance And Support Services; Remote Monitoring And Assistance Services
Companies Mentioned: Ottobock SE & Co. KGaA; Shanghai Fourier Intelligence Co. Ltd.; Kinova Inc.; Cyberdyne Inc.; Hocoma AG; Myomo Inc.; Neofect Co. Ltd.; Ekso Bionics Holdings Inc.; ReWalk Robotics Ltd.; AlterG Inc.; RENU ROBOTICS CORPORATION; ExoAtlet Global S.A.; REEV Robotics; Bionik Laboratories Corp.; Rex Bionics PLC; Wearable Robotics Srl; Gogoa Mobility Robots S.L.; Technaid S.L.; Bionic Yantra Pvt. Ltd.; MediTouch Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this AI-Enhanced Neurorehabilitation Exoskeleton market report include:- Ottobock SE & Co. KGaA
- Shanghai Fourier Intelligence Co. Ltd.
- Kinova Inc.
- Cyberdyne Inc.
- Hocoma AG
- Myomo Inc.
- Neofect Co. Ltd.
- Ekso Bionics Holdings Inc.
- ReWalk Robotics Ltd.
- AlterG Inc.
- RENU ROBOTICS CORPORATION
- ExoAtlet Global S.A.
- REEV Robotics
- Bionik Laboratories Corp.
- Rex Bionics PLC
- Wearable Robotics Srl
- Gogoa Mobility Robots S.L.
- Technaid S.L.
- Bionic Yantra Pvt. Ltd.
- MediTouch Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.47 Billion |
| Forecasted Market Value ( USD | $ 2.87 Billion |
| Compound Annual Growth Rate | 18.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
